Group items tagged

Cancer is a disease caused when cells divide abnormally and uncontrollably and spread into surrounding tissues, which results in formation of a mass called tumor. Head and neck cancer refers to various malignant tumors that develop in or around the mouth, sinuses, nose, larynx, and throat. Moreover, head and neck cancer begin in squamous cells that line moist surfaces such as those inside the throat, nose, and mouth. Infection with human papillomavirus (HPV), excessive alcohol consumption, and chewing tobacco increases the risk of head and neck cancer. Other factors such as hereditary causes, Epstein barr virus infection, radiation exposure, occupational exposure, oral health, salted or preserved foods, excessive consumption of paan also increases the risk of head and neck cancer. Factors such as rise in government initiatives, surge in research and development activities, rise in health care infrastructure, and increase in the patient population are expected to propel the head and neck cancer market. Worldwide, head and neck cancer is the sixth-most common cancer, with around 630,000 people diagnosed every year, resulting in more than 350,000 deaths, according to the National Center for Biotechnology Information. Moreover, tens of millions of individuals are diagnosed with cancer each year and more than half of the patients eventually die from it. Moreover, cancer ranks the second most common cause of death in many countries, following cardiovascular diseases. Read more @ https://sachinbhombe.blogspot.com/2021/03/insights-on-salicylic-head-and-neck.html

Metastatic osteosarcoma is one form of the disease osteoarthritis. It has been found that this disease occurs due to a problem with the cells in the spinal cord that are responsible for the proper function of the joints. The disease generally affects the aging group and those individuals suffering from other medical conditions like diabetes etc. The pain caused due to metastatic osteosarcoma can be so severe that it leads to tremendous disability to the affected person. Increasing drug pipeline for malignant bones and soft tissue cancer is expected to drive growth of the global metastatic osteosarcoma treatment market. Key biopharmaceutical and pharmaceutical companies are focused on research and development activities to synthesize novel drug treatment for soft tissue and malignant bone cancer. For instance, in September 2020, Junshi Biosciences, a major biopharmaceutical company, received the U.S. Food and Drug Administration (FDA) Orphan Drug designation to Toripalimab for the treatment of soft tissue sarcoma. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/metastatic-osteosarcoma-treatment.html

Pharmacovigilance, also called clinical pharmacology, is the clinical use of a drug in treating patients with certain disorders and diseases. Adverse drug events (ADRs), which include deaths from drug toxicity, can lead to severe medical consequences, as revealed in numerous studies about adverse drug reactions (ADR). To increase awareness about and educate patients about ADRs, more research in the area of ADRs and pharmacovigilance is required. In June 2020, the Food and Drug Administration (FDA) published a notice of intent to implement the National Pharmacy Ownership and Clinical Quality Improvement Organizations (NPHIA) guidelines on the regulation of pharmaceuticals and other medical products. The intention was to standardize the labeling and marketing of prescription and non-prescription drugs. The move resulted in the formation of the National Pharmacy Ownership and Clinical Quality Improvement Organizations (NPZA) and the National Institute for Drug Evaluation (NIDA). Although the new regulations established guidelines for the safe handling of pharmaceuticals, the problems still exist. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/how-pharmacovigilance-reduce-rate-of.html

An antacid is simply a substance that neutralizes stomach acids and is typically used to alleviate heartburn, gastric indigestion, or an upset stomach with food. Some antacids are being used in the treatment of diarrhea and constipation. More recently marketed antacids now contain sodium salts of aluminum, magnesium, calcium, or other substances. Antacids are available both over the counter and by prescription. Antacids neutralize stomach acid as they neutralize the alkaline substance in your stomach - the very substance that causes most of the discomfort! In order to be sure that antacids work, it is important to consult your doctor or pharmacist Growing geriatric population suffering GERD, i.e. gastroesophageal reflux disease is expected to drive growth of the global antacid medications market. According to the National Center for Biotechnology Information (NCBI), around 20% of adults in western culture are affected with GERD. According to the same source, the prevalence of GERD in the U.S. was between 18.1% and 27.8% in 2020. GERD is one of the most common gastrointestinal disorders among the geriatric population. According to the World Health Organization (WHO), by 2050, the global population aged 65 years and above is expected to reach around 2 billion increasing from 900 million in 2015. Read More @ https://coherentmarketinsights-blog.blogspot.com/2021/01/antacid-medications-market-is-expanding.html

High prevalence of gastric cancer is expected to propel growth of the gastric cancer therapeutics market. For instance, according to The American Cancer Society, the U.S. is estimated to record about 26,560 cases of stomach cancer and about 11,180 people will die from this type of cancer in 2021. Moreover, R&D in oral chemotherapy for the treatment of gastric cancer is also expected to aid in growth of the market. For instance, in January 2021, Ascelia Pharma AB announced the clinical development plan for Oncoral, with which the company has the opportunity to develop a novel oral chemotherapy for the treatment of gastric cancer. Risk factors for gastric cancer may include smoking and a diet of highly processed or salty foods. Thus, high number of smokers is expected to offer lucrative growth opportunities for players in the gastric cancer therapeutics market. For instance, according to the World Health Organization's, May 2020 Update, tobacco leads to over 8 million deaths each year worldwide and over 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-prevalence-of-gastric-cancer-and.html

Apheresis is an innovative medical procedure where the blood is extracted from the patient's body and then desired blood components (such as platelets, plasma, white cells, and red cells) are separated based on their weight and size. Depending on the cause of apheresis, one of these components is isolated and collected, while the other components are returned to the body. Apheresis is a blood purification procedure performed for blood donation component or for the treatment of disease. It is performed for various diseases such as hematological, autoimmune, renal, cardiovascular, neurological, and more. In apheresis procedure, the centrifuge therapeutic devices are used to separate desired blood components from the donor's blood. These blood components are separated based on their characteristics such as affinity for substance, molecular weight, and size among other factors. The emergence of COVID-19 is expected to propel the growth of the apheresis market. For instance, according to the Food and Drug Control Administration (Gujarat, India), there were 13 plasma apheresis units in the state before the pandemic, now the number has jumped to 28 to meet the requirement of plasma used in convalescent plasma therapy. Moreover, worldwide, as of 9:47am CET, 13 January 2021, there have been 90,054,813 confirmed cases of COVID-19, including 1,945,610 deaths, according to the World Health Organization (WHO). Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/emergence-of-covid-19-is-expected-to.html

Tissue Transplantation products and services are getting widely used in the healthcare sectors worldwide. The term Tissue Transplant refers to the process of adding new tissues to the body that is broken down and replaced by other organs or tissues. It is a major breakthrough in organ transplantation and is used more frequently. Tissue Transplantation is the practice of harvesting and replacing human organs such as kidneys, liver, heart valves, lungs, and bones with other healthy tissues from other people. Tissue Transplantation has given hope to many patients who have had to have a hip replaced or a kidney removed because of disease or illness. In recent years, there has been an increase in the number of people who are now choosing to donate their organs and tissues to medical research and treatment centers. More people are now aware of the need for organ donations and more people are now looking to give back to society than ever before. The demand for organ and tissue transplantation is increasing every day. Unhealthy food habits lack of exercise, drug abuse, and alcohol consumption results in organ failure, owing to which the demand for the Tissue Transplantation products and services market is estimated to rise. Increasing events of acute diseases are also estimated to aid the growth of the market. For instance, high blood pressure and diabetes are the main causes of end-stage renal diseases where kidney dialysis or transplant are the only options to save the patients. According to the U.S. Department of Health & Human Services, in 2019, there were approximately 122,913 patients in U.S. who needed urgent tissue transplants. Hence the increasing demand for advanced transplantation products is estimated to drive the market growth. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/the-global-tissue-transplantation.html

Anti-suicide drugs are the most commonly used pharmaceuticals that are prescribed for the treatment of schizophrenia and other mood disorders. The U.S. Food and Drug Administration (FDA) approved these medications in 1970. They are usually called antipsychotic medications. Although they are very helpful in controlling both the mania and depression, this medicine can prove to be very dangerous if taken in high doses even without an anesthetic. These medications are meant for temporary use only, therefore, care should be taken when using it so as not to cause any harmful side effects on the patient's health. Hence, people who have other illnesses should avoid using these medications. Antidepressants such as Clomipramine and Anafranil (Anafranil or Elavil) are some of the most commonly prescribed medications in the treatment for acute and chronic pain. They are effective in relieving the patient's discomfort and can also help him to come up with his life. However, there are reported cases where patients have experienced severe side effects such as confusion, hallucinations, drowsiness, dizziness, agitation, insomnia, and pupil contraction. Some patients may also experience headache, upset stomach, nausea, and diarrhea. Although these medications are very effective, they also have a number of side effects on the patient's health such as irregular heartbeat, blurred vision, and chest pain. Medications such as Carbamazepine, Lamotrigine, and Phenytoin are also known anti-suicide drugs. These medications act in a different way from other types of drugs. They work by altering the protein structures of neurons in the brain. Because of this, the patient's level of consciousness also differs from the patient who takes conventional antidepressant medications. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/02/emergence-of-covid-19-increases-cases.html

Enteral feeding devices technological advanced medical device used to deliver nutrition food directly to the stomach to the bedridden patient suffering from chronic diseases such as cancer and neurological disorder. The increase in the cases of malnutrition and premature birth cases around the globe is a prime factor driving growth of the enteral feeding devices market. Moreover, the growing prevalence of chronic diseases such as cancer and cardiovascular disease is another key factor fostering the market growth of the enteral feeding devices. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths occur due to cancer. Around 70% of deaths from cancer occur in low- and middle-income countries. Furthermore, increasing global expenditure on the healthcare sector for improving the patient care is further projected to augment the growth of the enteral feeding devices market. From the geographical perspective, North America is projected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population prone to chronic disease that leads to digestive ailments. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/enteral-feeding-devices-to-gain.html

Decline birth rate worldwide has led to the increasing adoption of various human reproductive technologies. For instance, according to the World Bank, Japan's birth rate, crude (per 1,000 people) decreased from 8.413 in 2005 to 7.4 in 2018. On the other hand, the increasing population has also led to the approval and launch of contraception products. In May 2020, Evofem Biosciences, Inc. received the U.S. Food and Drug Administration (FDA) approval for Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel used to prevent pregnancy in females of reproductive potential for use as an on-demand method of contraception. As the use of human reproductive technologies advances, there is increasing concern about ethical issues surrounding these medical interventions. While the use of fertility medication has been approved by the FDA, there are still questions about how to regulate it because of the fact that it is not a prescription and because of the inherent risks associated with using the technology. The first thing that we need to recognize is that the technology of artificial insemination has been around for decades. The only difference today is that we now have the ability to use technology to assist in the process of getting pregnant. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/declining-birth-rate-and-increasing.html

Over-the-counter drugs (also known as non-prescription drugs) are drugs that one can buy without a prescription. These drugs are widely used to treat conditions that do not require direct consultation. Moreover, over-the-counter drugs are effective and safe when a consumer follows the instructions on the label or is provided by a doctor. The Food and Drug Administration in the United States considers when a specific drug is safe and effective enough to be sold over-the-counter. Over-the-counter drugs are widely used to treat symptoms of cold and flu worldwide. Several pharmaceutical manufacturers are focused on converting Rx (prescription drugs) to OTC (over-the-counter drugs) to meet the increasing demand. In the first half of 2019, Tachipirina was the best-selling non-prescription medication (over-the-counter drug) in Italian pharmacies. Rx to OTC switch is the transfer of proven prescription drugs to nonprescription. In February 2020, the FDA converted three prescription drugs to over-the-counter drugs, increasing access to the medicines. Moreover, many people worldwide prefer OTC drugs to treat minor illnesses before seeking professional care. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/over-counter-drugs-are-safe-and.html

A pharmaceutical drug is a chemical substance that is used to cure, diagnose, treat, or protect disease. Some pharmaceutical drugs are sold in pharmacies and some are sold over-the-counter or as over-the-counter medications. Prescription drugs have many different applications, including the treatment of certain illnesses, but they also come in various forms that range from capsules, tablets, liquids, and lotions. One of the most popular and major types of pharmaceutical drugs is the oral form. These are drugs that can be taken by swallowing, which means that they need to pass through the stomach into the upper intestines where they are metabolized and digested into other substances. It is important to note that a certain amount of stomach acid is normal in the intestines and it helps digest food. Another popular type of pharmaceutical drug is an injectable. These are available as intravenous fluids and can be injected into a vein or through a catheter to deliver drugs to the body. Many people opt for these drugs because of their convenience and ability to be delivered right to where they need it. There are also synthetic drugs that can be used to treat many of the problems faced by the body. These drugs are sometimes more expensive than the ones prescribed from a doctor but are considered to be safer since they do not have as many side effects. Also, some of these drugs are more reliable than the prescription medication provided by a doctor. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/emergence-of-covid-19-adversely-impacts.html

Enteric diseases are caused by micro-organisms such as parasites, bacteria, and viruses that cause intestinal illness. Enteric disease is caused by bacteria that are found inside of the small intestine. The term enteric describes the area where these bacteria attach to the lining of the small intestine, and it is generally thought that there are approximately five hundred different strains of this type of bacteria. An individual is not necessarily at risk for developing enteric disease, but those who have a family history of the disease are particularly at risk. Enteric diseases most often result from consuming contaminated water or food and some can spread from person to person. The emergence of COVID-19 (the novel coronavirus) is expected to propel the growth of the enteric disease testing market. For instance, according to the World Health Organization (WHO), worldwide, as of 5:01pm CET, 11 February 2021, there have been 106,991,090 confirmed cases of COVID-19, including 2,347,015 deaths. Increasing prevalence of enteric diseases worldwide and increasing launches and approvals of new products are expected to drive the enteric disease testing market growth. For instance, in October 2019, Mobidiag received CE-IVD marking for its Novodiag Stool Parasites test for the detection of intestinal parasites from stool samples. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/the-emergence-of-covid-19-to-augment.html

Micro guide catheters are used in order to guide the urethra so that you can have an easy time inserting your pet's urethra and not be worried about any kind of blockage at all. There are many types of these devices available in the market. Some of these are manual tube and electric as well. Many people prefer to use micro guide catheters because they are made very simple and with great ease of use. A growing number of surgical procedures for treating cardiovascular diseases is fueling the growth of the micro guide catheters market. According to the American College of Cardiology Foundation, in 2017, emergency medical services-assessed out-of-hospital cardiac arrest occurred in an estimated 356,461 Americans; emergency medical services treatment was initiated in 52%. In the United States in 2019, coronary events are expected to occur in about 1,055,000 individuals, including 720,000 new and 335,000 recurrent coronary events. The increasing development of modern disposable catheters that are safer and more comfortable to insert is further projected to foster the growth of the micro guide catheters market. North America is projected to gain significant growth over the forecast period and this is attributed to the continuous launch of innovative products by ley players in the region. For instance, in March 2017, Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and the U.S. commercial launch of the TrapLiner Catheter. The TrapLiner Catheter was developed by Vascular Solutions Inc., which was acquired by Teleflex. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/rise-in-number-of-cardiovascular.html

Medical ceramics are ceramics that have the properties to be used as the direct medium of medical procedures. They are made from a number of different materials including porcelain, enamel, ceramic, polymers, and other materials. The ceramic material is used to serve the purpose of impregnating the substances on the affected part so that they get affected by the required heat and are changed into a non-toxic and safe substance. Increasing demand for implantable devices is expected to drive the growth of the global medical ceramics market. The demand for implantable devices offer additional advantages including the ability to selectively activate grouping of fibers within the nerve. Major companies operating in the market are focused on research and development activities, in order to gain a significant edge in the competition. For instance, in December 2020, W. L. Gore and Associates, Inc. received the U.S. Food and Drug Administration (FDA) approval for its Gore Excluder Comfortable (EXCC) AAA Endoprosthesis to treat patients with aneurysm of the infrarenal abdominal aorta. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/medical-ceramics-market-is-expanding.html

Chronic renal failure, or renal overload, is associated with a variety of morbidity and mortality and is a major challenge in the clinical treatment of patients with chronic renal failure. This disease has no cure and can be managed with specific medications in an appropriate course of therapy. However, in patients for whom other therapies have been ineffective or who are experiencing life-threatening side effects, continuous renal substitute therapy (CRS) is the only feasible treatment. Continuous Renal Replacement Therapy (CRRT) is a type of blood purification therapy used in the treatment of patients with acute kidney injury. The therapy is commonly used to provide renal support for critically ill patients with acute kidney injury, particularly patients who are hemodynamically unstable. Emergence of COVID-19 has led to increasing adoption of CRRT as patients with Covid-19 are experiencing multiple organ failure, including acute kidney injury. Moreover, regulatory bodies are also focused on approval and launch of new CRRT devices. For instance, in April 2020, The U.S. Food and Drug Administration granted marketing authorization for a new device indicated to provide continuous hemodialysis or hemofiltration therapy to critically ill pediatric patients weighing between 2.5 and 10 kilograms (or 5.5 to 22 pounds). Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/demand-for-continuous-renal-replacement.html

Endoscopy is a procedure that has been developed to assist in the removal of endometriosis from the human body. Endoscopy is also being used to help in the treatment of gallstones, cholecystitis, and gastric reflux disease among a number of other conditions. The recent developments in this industry have been driven by changes in government regulation and legislation. The increase in the number of malignancies and the introduction of fiscal policy in the region has resulted in political will on the part of the governments to strengthen public health services. Rising product approval for endoscopy devices by regulatory authorities is expected to drive growth of the global endoscopic stricture management device market during the forecast period. For instance, in January 2020, Pentax Medical received the U.S. Food and Drug Administration (FDA) approval for its Imagina Endoscopy System, which will be used in performing gastrointestinal procedures, digital image enhancement system with Pentax i-Scan. This endoscopy machine is equipped with an LED touch-screen interface, which removes the need for periodic bulb replacement. Besides, it is far more cost-efficient than the GI endoscopy system such as video endoscopy. Thus. These factors are expected to drive growth of the global endoscopic stricture management device market during the forecast period. Furthermore, increasing incidence of bleeding during surgical procedures combined with growing number of endoscopic procedures is expected to boost the global endoscopic stricture management device market growth over the forecast period. However, the lack of skilled healthcare professionals to perform surgical procedures, especially in emerging economies combined with complications related to endoscopic procedures such as bleeding and infection is expected to hamper the global endoscopic stricture management device market growth over the forecast period. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/end

Hyperphosphatemia is a condition caused by high levels of phosphorous or phosphate in the blood. This condition may be due to decreased emission of phosphate, excessive intake of phosphate, and the shift of phosphate from intracellular to extracellular. High phosphate levels in the blood can be avoided with the use of phosphate binders or by dietary restrictions. Phosphate is a chemical found in the human body and contains a mineral called phosphorous. It is important for the development of bones and teeth and also converts food into energy for the body. Some other possible causes of hyperphosphatemia include low levels of parathyroid hormone, high levels of vitamin D, uncontrolled diabetes, and diabetic ketoacidosis. The factors such as the growing geriatric population and increasing prevalence of chronic diseases worldwide are expected to drive the hyperphosphatemia drugs market in the coming future. Hyperphosphatemia is a primary cause of mortality and morbidity in people with chronic kidney disease. According to the Centers for Disease Control and Prevention (CDC), around 37 million adults in the United States are likely to have chronic kidney disease and most are undiagnosed. It is rare in the general population, but in people with chronic kidney disease, the rate of hyperphosphatemia is at least 70%. Since the increased risk of death from heart disease and hyperphosphatemia are associated with each other. This, in turn, increases the risk of heart disease in people suffering from hyperphosphatemia. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-prevalence-of-chronic-kidney.html